APA (7th ed.) Citation

ME, C., J, P., ES, D., MR, N., MR, P., SS, A., . . . MP, B. (2026). Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial. Circulation. Cardiovascular interventions, 19(5), e015229. https://doi.org/10.1161/CIRCINTERVENTIONS.125.015229

Chicago Style (17th ed.) Citation

ME, Canonico, et al. "Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial." Circulation. Cardiovascular Interventions 19, no. 5 (2026): e015229. https://doi.org/10.1161/CIRCINTERVENTIONS.125.015229.

MLA (9th ed.) Citation

ME, Canonico, et al. "Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial." Circulation. Cardiovascular Interventions, vol. 19, no. 5, 2026, p. e015229, https://doi.org/10.1161/CIRCINTERVENTIONS.125.015229.